Doctors Perform US' 1st Penis Transplant
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
A 64-year-old man in Massachusetts has become the first person in the United States to receive a penis transplant, doctors announced today.
The patient, Thomas Manning, needed his penis removed in 2012 because of aggressive penile cancer. The penile transplant was performed in order to reconstruct the genitalia so it has a more natural appearance, restore urinary function and hopefully achieve sexual function, the doctors said.
"We are hopeful that these reconstructive techniques will allow us to alleviate the suffering and despair of those who have experienced devastating genitourinary injuries and are often so despondent they consider taking their own lives," Dr. Curtis Cetrulo, of the Massachusetts General Hospital (MGH) Division of Plastic and Reconstructive Surgery, said in a statement.
The penile transplant surgery, called a genitourinary vascularized composite allograft, or GUVCA, took 3 and a half years to plan. The 15-hour operation involved connecting the blood vessels and nerves of a penis from a deceased donor onto the blood vessels and nerves of the patient. [8 Wild Facts About the Penis]
So far, the patient has not had signs of organ rejection or infection, which are potential complications of the procedure.
Right now the procedure is considered experimental, but as doctors learn more, they hope to offer the transplant to more patients, including combat veterans who have experienced significant injuries to the genitals, the doctors said.
"We are delighted to have taken the first steps to help those patients who have suffered silently for far too long," said Dr. Dicken S.C. Ko, a urologist and transplant surgeon, also at MGH.
Get the world’s most fascinating discoveries delivered straight to your inbox.
In a statement, Manning said, "Today I begin a new chapter filled with personal hope and hope for others who have suffered genital injuries, particularly for our service members who put their lives on the line and suffer serious damage as a result.
"In sharing this success with all of you, it's my hope we can usher in a bright future for this type of transplantation," Manning said.
Previously, penis transplants have been performed in South Africa and China.
Follow Rachael Rettner @RachaelRettner. Follow Live Science @livescience, Facebook & Google+. Original article on Live Science.

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.
